EASTMAN CHEMICAL CO (EMN) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.77%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.77% | Research and development expense / revenue. Period ending 2026-06-30. $246.00M ÷ $8.87B × 100 ≈ 2.77% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 246.00M USD | Research and Development Expense |
| Revenue | 8.87B USD | |
| Stock-based compensation | (m) | |
| Operating income | (m) | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $246.00M | $8.87B | (m) | (m) | (m) | 2.77% | (m) | (m) | (m) |
| 2026-03-31 | $248.00M | $8.64B | (m) | (m) | (m) | 2.87% | (m) | (m) | (m) |
| 2025-12-31 | $255.00M | $8.75B | (m) | (m) | (m) | 2.91% | (m) | (m) | (m) |
| 2025-09-30 | $263.00M | $9.02B | (m) | (m) | (m) | 2.91% | (m) | (m) | (m) |
| 2025-06-30 | $265.00M | $9.29B | (m) | (m) | (m) | 2.85% | (m) | (m) | (m) |
| 2025-03-31 | $258.00M | $9.36B | (m) | (m) | (m) | 2.76% | (m) | (m) | (m) |
| 2024-12-31 | $250.00M | $9.38B | (m) | (m) | (m) | 2.66% | (m) | (m) | (m) |
| 2024-09-30 | $241.00M | $9.34B | (m) | (m) | (m) | 2.58% | (m) | (m) | (m) |
| 2024-06-30 | $236.00M | $9.15B | (m) | (m) | (m) | 2.58% | (m) | (m) | (m) |
| 2024-03-31 | $236.00M | $9.11B | (m) | (m) | (m) | 2.59% | (m) | (m) | (m) |
| 2023-12-31 | $239.00M | $9.21B | (m) | (m) | (m) | 2.60% | (m) | (m) | (m) |
| 2023-09-30 | $246.00M | $9.38B | (m) | (m) | (m) | 2.62% | (m) | (m) | (m) |
| 2023-06-30 | $254.00M | $9.82B | (m) | (m) | (m) | 2.59% | (m) | (m) | (m) |
| 2023-03-31 | $261.00M | $10.28B | (m) | (m) | (m) | 2.54% | (m) | (m) | (m) |
| 2022-12-31 | $264.00M | $10.58B | (m) | (m) | (m) | 2.50% | (m) | (m) | (m) |
| 2022-09-30 | $267.00M | $10.90B | (m) | (m) | (m) | 2.45% | (m) | (m) | (m) |
| 2022-06-30 | $265.00M | $10.91B | (m) | (m) | (m) | 2.43% | (m) | (m) | (m) |
| 2022-03-31 | $261.00M | $10.78B | (m) | (m) | (m) | 2.42% | (m) | (m) | (m) |
| 2021-12-31 | $254.00M | $10.48B | (m) | (m) | (m) | 2.42% | (m) | (m) | (m) |
| 2021-09-30 | $244.00M | $9.97B | (m) | (m) | (m) | 2.45% | (m) | (m) | (m) |
| 2021-06-30 | $234.00M | $9.37B | (m) | (m) | (m) | 2.50% | (m) | (m) | (m) |
| 2021-03-31 | $223.00M | $8.64B | (m) | (m) | (m) | 2.58% | (m) | (m) | (m) |
| 2020-12-31 | $226.00M | $8.47B | (m) | (m) | (m) | 2.67% | (m) | (m) | (m) |
| 2020-09-30 | $229.00M | $8.49B | (m) | (m) | (m) | 2.70% | (m) | (m) | (m) |
| 2020-06-30 | $232.00M | $8.70B | (m) | (m) | (m) | 2.67% | (m) | (m) | (m) |
| 2020-03-31 | $237.00M | $9.13B | (m) | (m) | (m) | 2.59% | (m) | (m) | (m) |
| 2019-12-31 | $234.00M | $9.27B | (m) | (m) | (m) | 2.52% | (m) | (m) | (m) |
| 2019-09-30 | $233.00M | $9.44B | (m) | (m) | (m) | 2.47% | (m) | (m) | (m) |
| 2019-06-30 | $234.00M | $9.67B | (m) | (m) | (m) | 2.42% | (m) | (m) | (m) |
| 2019-03-31 | $237.00M | $9.92B | (m) | (m) | (m) | 2.39% | (m) | (m) | (m) |
| 2018-12-31 | $235.00M | $10.15B | (m) | (m) | (m) | 2.32% | (m) | (m) | (m) |
| 2018-09-30 | $217.00M | $10.14B | (m) | (m) | (m) | 2.14% | (m) | (m) | (m) |
| 2018-06-30 | $216.00M | $10.05B | (m) | (m) | (m) | 2.15% | (m) | (m) | (m) |
| 2018-03-31 | $214.00M | $9.85B | (m) | (m) | (m) | 2.17% | (m) | (m) | (m) |
| 2017-12-31 | $215.00M | $9.55B | (m) | $1.53B | (m) | 2.25% | (m) | (m) | (m) |
| 2017-09-30 | $221.00M | $9.38B | (m) | $1.53B | (m) | 2.36% | (m) | (m) | (m) |
| 2017-06-30 | $219.00M | $9.20B | (m) | $1.43B | (m) | 2.38% | (m) | (m) | (m) |
| 2017-03-31 | $219.00M | $9.07B | (m) | $1.38B | (m) | 2.41% | (m) | (m) | (m) |
| 2016-12-31 | $219.00M | $9.01B | (m) | $1.38B | (m) | 2.43% | (m) | (m) | (m) |
| 2016-09-30 | $246.00M | $9.04B | (m) | $1.30B | (m) | 2.72% | (m) | (m) | (m) |
| 2016-06-30 | $247.00M | $9.21B | (m) | $1.38B | (m) | 2.68% | (m) | (m) | (m) |
| 2016-03-31 | $249.00M | $9.44B | (m) | $1.47B | (m) | 2.64% | (m) | (m) | (m) |
| 2015-12-31 | $251.00M | $9.65B | (m) | $1.38B | (m) | 2.60% | (m) | (m) | (m) |
| 2015-09-30 | $239.00M | $9.77B | (m) | $1.24B | (m) | 2.45% | (m) | (m) | (m) |
| 2015-06-30 | $231.00M | $9.74B | (m) | $1.15B | (m) | 2.37% | (m) | (m) | (m) |
| 2015-03-31 | $230.00M | $9.66B | (m) | $1.11B | (m) | 2.38% | (m) | (m) | (m) |
| 2014-12-31 | $227.00M | $9.53B | (m) | $1.16B | (m) | 2.38% | (m) | (m) | (m) |
| 2014-09-30 | $210.00M | $9.44B | (m) | $1.70B | (m) | 2.22% | (m) | (m) | (m) |
| 2014-06-30 | $202.00M | $9.37B | (m) | $1.84B | (m) | 2.16% | (m) | (m) | (m) |
| 2014-03-31 | $197.00M | $9.35B | (m) | $1.83B | (m) | 2.11% | (m) | (m) | (m) |
| 2013-12-31 | $193.00M | $9.35B | (m) | $1.86B | (m) | 2.06% | (m) | (m) | (m) |
| 2013-09-30 | $210.00M | $9.25B | (m) | $1.26B | (m) | 2.27% | (m) | (m) | (m) |
| 2013-06-30 | $214.00M | $9.18B | (m) | $1.04B | (m) | 2.33% | (m) | (m) | (m) |
| 2013-03-31 | $206.00M | $8.59B | (m) | $929.00M | (m) | 2.40% | (m) | (m) | (m) |
| 2012-12-31 | $198.00M | $8.10B | (m) | $800.00M | (m) | 2.44% | (m) | (m) | (m) |
| 2012-09-30 | $180.00M | (m) | (m) | $863.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $169.00M | (m) | (m) | $871.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $163.00M | (m) | (m) | $971.00M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $158.00M | (m) | (m) | $1.02B | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $160.00M | (m) | (m) | $1.02B | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $161.00M | (m) | (m) | $1.03B | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $155.00M | (m) | (m) | $957.00M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $152.00M | (m) | (m) | $862.00M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | $151.00M | (m) | (m) | $689.00M | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $141.00M | (m) | (m) | $600.00M | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | $139.00M | (m) | (m) | $474.00M | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $137.00M | (m) | (m) | $317.00M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $158.00M | (m) | (m) | $519.00M | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $156.00M | (m) | (m) | $504.00M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |
| DuPont de Nemours, Inc. (DD) | United States | $17.580B | 1,010.90 |
| DOW INC. (DOW) | United States | $20.577B | -11.55 |